logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
E

Elena Giudice

Fondazione Policlinico Universitario A. Gemelli IRCCS
H指数:10
被引数:448

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intermittent olaparib with neoadjuvant platinum-based chemotherapy in BRCA mutant unresectable ovarian cancer: the NUVOLA trial.

奥拉帕利间歇性治疗联合新辅助铂类化疗在BRCA突变不可切除卵巢癌中的疗效：NUVOLA试验。

International Journal of Gynecological Cancer
IF4.7
2026-06-190
PRE
Vanda Salutari; Claudia Marchetti; Elena Giudice; Camilla Nero; Diana Giannarelli; Viola Ghizzoni; Sara Lardino; Carolina Maria Sassu; Barbara Costantini; Giulia Ponti; Gian Franco Zannoni; Giovanni Scambia; Anna Fagotti
Durvalumab and cediranib with and without olaparib in recurrent ovarian cancer: a phase II proof-of-concept study

Durvalumab和cediranib联合或不联合olaparib治疗复发性卵巢癌：一项II期概念验证研究

Nature Communications
IF15.7
2026-03-160
OAAI
Junya Tabata; Tzu-Ting Huang; Elena Giudice; Kristen R. Ibanez; Jayakumar R. Nair; Aanika Balaji Warner; Britanny B. Solarz; Valentina Bolanos; Bernadette Redd; Nahoko Sato; Shraddha Rastogi; Sunmin Lee; Roshan L. Shrestha; Alexander Y. Mitrophanov; Stanley Lipkowitz; Kevin Conlon; Chien Chu Huang; Jung-Min Lee
Neoadjuvant Chemotherapy Followed by Interval Surgery versus Primary Debulking Surgery in FIGO Stage III–IV Epithelial Ovarian Cancer: A Systematic Review and Meta-Analysis

新辅助化疗后间隔手术与初始肿瘤细胞减灭术在FIGO III–IV期上皮性卵巢癌中的应用比较：一项系统评价和Meta分析

European Journal of Cancer
IF7.1
2025-11-150
PRE
Matteo Secchi; Mauro Signorelli; Eliana Rulli; Matteo Maruccio; Giampaolo Di Martino; Daria Spadaro; Elena Giudice; Margherita Turinetto; Fabio Landoni; Stefano Restaino; Giuseppe Vizzielli; Fabio Martinelli; Domenica Lorusso
Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009–2023)

癌症临床试验中与FDA药物审批相关的患者入组标准及基线特征（2009–2023）

European Journal of Cancer
IF7.1
2025-06-260
OA
Giovanni Maria Iannantuono; Charalampos S. Floudas; Marco Filetti; Tommaso Giovagnoli; Stefano Sganga; Antonio Vitale; Elias Chandran; Pasquale Lombardi; Roberto Rosenfeld; Elena Giudice; Elisabetta Xue; Elvira Rapisarda; Paola Troisi; Andrea B. Apolo; Fatima Karzai; Emilio Bria; James L. Gulley; Gennaro Daniele
Performance status restrictions in clinical trials leading to US food and drug administration (FDA) drug approval: A cross-sectional study of a decade (2014-2023)

临床 trials 中 performance status 限制与 US food and drug administration (FDA) 药物审批的关系：一项跨越十年（2014-2023）的横断面研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Iannantuono, G. M.; Filetti, M.; Giudice, E.; Sganga, S.; Chandran, E. B. A.; Xue, E.; Lombardi, P.; Rosenfeld, R.; Rapisarda, E.; Ferri, L.; De Rubeis, G.; Lorusso, D.; Floudas, C.; Gulley, J. L.; Apolo, A. B.; Lee, J-M.; Karzai, F.; Altamura, V.; Scambia, G.; Daniele, G.
A randomized, molecular driven phase II trial of carboplatin-paclitaxel-bev vs carboplatin-paclitaxel-bev-rucaparib vs carboplatin-paclitaxel-rucaparib, selected according to HRD status, in patients with advanced ovarian cancer
ANNALS OF ONCOLOGY
IF65.4
2022-06-011
OA
Scambia, G.; Salutari, V.; Musacchio, L.; Siena, S.; Pignata, S.; Zavallone, L.; Valabrega, G.; Cormio, G.; Mosconi, A. M.; Ricci, C.; Ghizzoni, V.; Carbone, M. V.; Giudice, E.; Camarda, F.; Nero, C.; Tronconi, F.; Lorusso, D.
Randomized phase III trial on niraparib - TSR-042 (dostarlimab) vs physician's choice CHEmotherapy in recurrent ovarian, fallopian tube or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33)
ANNALS OF ONCOLOGY
IF65.4
2021-09-010
OAAI
Lorusso, D.; Musacchio, L.; Pignata, S.; Braicu, E. I.; Cibula, D.; Colombo, N.; Frenel, J-S.; Zagouri, F.; Carbone, V.; Ghizzoni, V.; Giolitto, S.; Giudice, E.; Landolfo, C.; Perri, M. T.; Ricci, C.; Salutari, V.; Scambia, G.

研究方向

暂未获取到该数据
G
Giovanni Scambia
H 指数:117论文数:3,225被引数:9.1万
D
Domenica Lorusso
H 指数:77论文数:969被引数:3.8万
L
Lucia Musacchio
H 指数:17论文数:83被引数:968
M
Maria Teresa Perri
H 指数:13论文数:66被引数:890
V
Vanda Salutari
H 指数:34论文数:197被引数:3,901
C
Caterina Ricci
H 指数:20论文数:72被引数:2,471
C
Camilla Nero
H 指数:26论文数:193被引数:1,802
F
Floriana Camarda
H 指数:10论文数:87被引数:490
M
Maria Vittoria Carbone
H 指数:6论文数:36被引数:235
C
Charalampos S. Floudas
H 指数:18论文数:123被引数:1,889